YD Bio Ltd YDES
6.03 USD -0.68 (-10.13%)
At closeNov 10, 2026, 4:00 PM EST
6.20 +0.17 +2.82%
After hours · Nov 10, 4:00 PM ET
5.90 Day range 6.95
1.70 52-week range 15.72
- YTD
- -50.53%
- 1 year
- -30.45%
- Market cap
- 427.11M
- Revenue (ttm)
- 510.36K
- Profit margin
- -276.58%
- EPS (ttm)
- -0.04
- Shares out
- 70.52M
- YTD return
- -50.53%
- 1-year return
- -30.45%
- Volume
- 103.13K
- Avg volume
- 309.72K
- Open
- 6.50
- Previous close
- 6.71
- Day's range
- 5.90 – 6.95
- 52-week range
- 1.70 – 15.72
- Beta
- 0.16
No chart data for this range yet.
Key statistics
- Enterprise value
- 19.67M
- PEG ratio
- 0.00
- Price / sales
- 1829.50
- Price / book
- 2.90
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 95.60%
- Free cash flow
- -3.88M
- Total cash
- 3.13M
- Total debt
- 22.27K
- Return on equity
- -42.69%
- Short % of float
- 0.52%
- 50-day average
- 17.26
- 200-day average
- 17.26
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
YDES Revenue — quarterly 510.36K
YDES Net income — quarterly 1.31M
YDES EPS — quarterly 0.09
About YD Bio Ltd
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Taiwan
- Website
- ydesgroup.com
News
Your note
Sign in to keep a note on YDES — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Cerity Partners LLC | 0.05% | 32,406 | 429.06K | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 0.03% | 20,862 | 276.21K | Sep 29, 2025 |